Molecular Diagnostics
POC Test Detects Genetic Blood Disorders with High Accuracy
Sickle cell disease (SCD) and beta thalassemia are genetic blood disorders that affect over 7% of the global population. In the US, SCD is estimated to affect 100,000 people, with up to 8% of African-Americans being carriers, and can reduce life expectancy by up to 20 years. Now, an affordable sickle cell and beta thalassemia test that is currently used in 27 countries seeks to replicate its international success and expand into the U.S. More...31 Mar 2023
Non-Invasive Fecal DNA Test Accurately Detects Colorectal Cancer and Precancerous Lesions
BGI Genomics has developed a non-invasive fecal DNA test, known as COLOTECTTM 1.0, to detect colorectal cancer and precancerous lesions. The test employs multiplex methylation-specific PCR (MSP) technology to track abnormal DNA-methylation biomarkers in stool samples. More...30 Mar 2023
Simple Blood Test Could Help Doctors Diagnose Heart Disease in Physician's Office
In the largest analysis of blood RNA from patients with angiographically confirmed coronary artery disease (CAD), researchers have demonstrated how RNA biomarkers could be utilized to confirm heart disease. More...30 Mar 2023
Serum Protein Test Can Predict Outcomes for Liver Failure Patients
A new study has revealed that levels of a serum protein called carbamoyl phosphate synthetase 1 (CPS1), which is short-lived but abundant, can accurately predict outcomes for patients with acute liver failure - whether they will recover or require a transplant. More...29 Mar 2023
Fully Automated Blood-Based Assays Measure Biomarker for Neurodegenerative Diseases within 35 Minutes
Fujirebio has launched the fully automated Lumipulse G NfL CSF and Lumipulse G NfL Blood CLEIA (chemiluminescent enzyme immunoassay) assays for the LUMIPULSE G immunoassay systems that enable the quantitative measurement of neurofilament light (NfL) in human Cerebrospinal fluid (CSF) and plasma/serum, respectively, in only 35 minutes. More...29 Mar 2023
POC Fingerprick Test Identifies Both HIV-1/2 and Syphilis Antibodies from One Sample within 60 Seconds
A new test is designed to detect antibodies for both HIV-1/2 and syphilis using a single sample obtained through a simple fingerprick method. The test delivers accurate results in under a minute, while being mobile and easy to use. More...29 Mar 2023
Transformative NGS Innovation Expands Access to Genomic Testing for Tuberculosis Patients
The WHO has identified tuberculosis (TB) as the leading global bacterial infectious killer, causing more than 1.5 million deaths each year. Despite the possibility of a cure with appropriate treatment, multidrug-resistant TB (MDR TB) has become a significant global public health emergency. Now, the combined use of a targeted next-generation sequencing (NGS) based test and novel NGS platforms will allow much more rapid determination of extensive drug resistance profiles and TB strain types. More...28 Mar 2023
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
Gold Member
Hematology Analyzer
Medonic M32B
Gold Member
Immunochromatographic Assay
CRYPTO Cassette
 assay.jpg)
New
Gold Member
Ketosis and DKA Test
D-3-Hydroxybutyrate (Ranbut) Assay
In Other News
Quick, Affordable Finger-Prick Test Diagnoses Common STI in Five Minutes
Automated Sample-to-Result PCR Test Enables Rapid Genotyping for Antiplatelet Therapy
Handheld Molecular POCT System Enables Rapid Onsite Testing at Hospital ERs and Clinics
Next Gen Technology Enables Robust, Straightforward and Flexible Molecular Diagnostics in Any Environment
Portable PCR Molecular Analyzer Delivers Time-Critical Results in Near-Patient Setting
First-of-Its-Kind Test Helps Determine Future Risk of Esophageal Cancer
Handheld Immunoanalyzer Performs Laboratory Tests near Patient without Sacrificing Sensitivity and Precision
Point-of-Care MDx System Enables Simple, Fast and Accurate Diagnosis in Near Patient Setting
Near-Patient Molecular Test Outperforms Other Rapid Measures for Sepsis Diagnosis
Biomarker-Based Approach Could Identify Early Risk of Pancreatic Cancer
Simple, Inexpensive Genetic Test Can Identify MS Patients at Risk of Fatal Brain Infection
Unique Dye-Based Tests to Revolutionize Early-Detection Pancreatic Cancer Diagnostics
Novel Lymph Liquid Biopsy Could Transform Approach for Identifying Cancer Recurrence Risk
First-of-Its-Kind High-Throughput Diagnostic Test for Infectious Vaginitis Uses Only One Swab
Novel Biosensor to Detect DNA Damage in Real Time Could Revolutionize Cancer Treatment
High-Sensitivity Troponin I Could Predict Preeclampsia in High-Risk Women
‘Glow-In-The-Dark’ Proteins to Help Diagnose Viral Diseases More Quickly and Easily
Novel Test to Ensure Essential Treatment for Newborns with Serious Genetic Disease
Affordable Blood-Based Test Provides Early Detection of Colorectal Cancer
Novel Non-Sputum Based Technology Quickly and Easily Detects Active TB
Rapid PCR Diagnostic Test for STIs Provides Accurate Results in Less than 30 Minutes at POC
Urine-Based Molecular Test Detects Bladder Cancer Quickly and Accurately
Urine Gene Test Could Detect Bladder Cancer Years Before Symptoms Arise
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.
